ClinicalTrials.gov
ClinicalTrials.gov Menu

A Dose-escalation Safety Trial for Intrathecal Autologous Mesenchymal Stem Cell Therapy in Amyotrophic Lateral Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01609283
Recruitment Status : Active, not recruiting
First Posted : May 31, 2012
Last Update Posted : January 12, 2018
Sponsor:
Information provided by (Responsible Party):
Anthony J. Windebank, Mayo Clinic